Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 215025

In scope icon M 7 A
QID 215025 (Type "215025" in App Search)
A 32-year-old G2P1 woman at 26 weeks of gestation presents to her obstetrician for a routine visit. She has no history of chickenpox and does not have a prior varicella vaccine. She has been receiving routine prenatal care since she found out she was pregnant at 5 weeks of gestation. She has 1 prior uncomplicated vaginal delivery. The patient notes that she was babysitting her niece and nephew a few days ago who were home sick from school with a very itchy, erythematous, vesicular body rash. Her temperature is 98.9°F (37.2°C), blood pressure is 130/89 mmHg, pulse is 98/min, and respirations are 12/min. Physical examination reveals a gravid uterus with a fundal height of 26 cm. No rashes are noted. Which of the following is the most appropriate next step in the management of this patient?

Administer recombinant zoster vaccine

0%

0/31

Administer varicella vaccine

3%

1/31

Administer varicella zoster virus immune globulin

35%

11/31

Conduct serology for varicella zoster virus IgG

42%

13/31

Continue with routine prenatal care

13%

4/31

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

This patient's recent history of close contact with her niece and nephew, who have rashes that are consistent with chickenpox, suggests that she was recently exposed to the varicella-zoster virus. Given her recent exposure, she requires post-exposure prophylaxis with varicella zoster immune globulin (VZIG) to prevent the development of varicella infection in the mother and fetus (as she has never had the vaccine or disease in the past).

VZIG provides passive varicella immunity to the mother in the form of anti-varicella antibodies and is safe to give during pregnancy. It is used in individuals who are exposed to varicella and are ineligible for the varicella vaccine or are at high risk for severe infection or complications. It is administered as a single dose intramuscularly and must be given within 10 days of exposure. Since many individuals will still develop varicella infection after immunoprophylaxis, the patient will require monitoring for 1 month after exposure.

The Centers for Disease Control and Prevention (CDC) discusses recommendations for the use VZIG. The authors find that VZIG administered within 4 days is as effective as administration within 10 days. The authors recommend administering VZIG to eligible patients as soon as possible.

Incorrect Answers:
Answer 1: Administering recombinant zoster vaccine is incorrect because it is a live vaccine which is contraindicated during pregnancy. It is used in older adults to prevent shingles rather than to protect against varicella exposure. This patient was exposed to varicella through her niece and nephew who have chickenpox, and therefore she needs protection specifically against varicella.

Answer 2: Administering the varicella vaccine is contraindicated during pregnancy because it is a live vaccine and can cause congenital varicella syndrome in the fetus.

Answer 4: Conducting serology for VZV IgG would be used to check the patient's immunity status against varicella. Regardless of the patient’s prior vaccination history or immunity status, exposure to varicella during pregnancy needs to be managed with VZIG to prevent infection of the mother and fetus.

Answer 5: Continuing with routine prenatal care would not protect the patient and her fetus from developing varicella infection. Therefore, the most appropriate next step in management is to administer VZIG.

Bullet Summary:
Exposure to varicella during pregnancy should be managed with varicella zoster immune globulin (VZIG) and avoiding live vaccines.

REFERENCES (1)
Authors
Rating
Please Rate Question Quality

5.0

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(2)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options